US Patent Number
A process is disclosed for producing an avirulent attenuated live virus vaccine for use in immunizing horses against equine viral arteritis and for simultaneously obviating the transmission of the disease from a vaccinated horse to a non-vaccinated horse. The invention also includes the product derived from practice of the process and typical examples of the efficacy of the product are disclosed.
University of Kentucky Research Foundation, Lexington, Ky.
Bryans, John T.; McCollum, William H.; Wilson, James C.; and Doll, Elvis R., "Process of Producing Equine Viral Arteritis Vaccine and Product Thereof" (1971). Veterinary Science Faculty Patents. 9.